Currently, the blue
perovskite light-emitting diodes (PeLEDs) suffer
from a compromise in lead toxicity and poor operation stability, and
most previous studies have struggled to meet the crucial blue NTSC
standard. In this study, electrically driven deep-blue LEDs (∼445
nm) based on zero-dimensional (0D) Cs3Cu2I5 nanocrystals (NCs) were demonstrated with the color coordinates
of (0.16, 0.07) and a high external quantum efficiency of ∼1.12%,
comparable with the best-performing blue LEDs based on lead-halide
perovskites. Encouraged by the remarkable stability of Cs3Cu2I5 NCs against heat and environmental oxygen/moisture,
the proposed device was operated in a continuous current mode for
170 h, producing a record half-lifetime of ∼108 h. The device
stability was further verified by an aggressive thermal cycling test
(300–360–300 K) and a 35-day storage test. Together
with the eco-friendly features and facile colloidal synthesis technique,
the 0D Cs3Cu2I5 NCs can be therefore
regarded as a promising candidate for deep-blue LEDs applications.
A 2D surface plasmon photonic crystal (SPPC) is achieved by implanting gold nanorods onto the periodic surface apertures of the poly(methyl methacrylate) (PMMA) opal photonic crystals. On the surface of the SPPC, the overall upconversion luminescence intensity of NaYF4 :Yb(3+) , Er(3+) under 980 nm excitation is improved more than 10(3) fold. The device is easily shifted to a transparent flexible substrate, applied to flexible displays.
We proposed a strategy of employing water-induced Cs3Bi2Br9/BiOBr nanocomposites to achieve a substantial enhancement in photoluminescence quantum yield by ∼130%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.